1 |
Niibe Y, Kenjo M, Onishi H, et al (2010). High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007). Jpn J Clin Oncol, 40, 795-9.
DOI
ScienceOn
|
2 |
Palma DA, Verbakel WF, Otto K, Senan S (2010). New developments in arc radiation therapy: a review. Cancer Treat Rev, 36, 393-9.
DOI
ScienceOn
|
3 |
Pesee M, Krusun S, Padoongcharoen P (2010). High dose rate cobalt-60 afterloading intracavitary therapy of uterine cervical carcinomas in Srinagarind hospital - analysis of complications. Asian Pac J Cancer Prev, 11, 491-4.
|
4 |
Rose PG, Bundy BN, Watkins EB, et al (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med, 340, 1144-53.
DOI
ScienceOn
|
5 |
Saibishkumar EP, Patel FD, Sharma SC (2006). Evaluation of late toxicities of patients with carcinoma of the cervix treated with radical radiotherapy: an audit from India. Clin Oncol (R Coll Radiol), 18, 30-7.
DOI
ScienceOn
|
6 |
Suzuki Y, Nakano T, Arai T, et al (2000). Progesterone receptor is a favorable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys, 47, 1229-34.
DOI
ScienceOn
|
7 |
Kim HJ, Kim S, Ha SW, Wu HG (2008). Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer? Tumori, 94, 327-32.
|
8 |
Lanciano RM, Martz K, Montana GS, Hanks GE (1992). Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A patterns of care study. Cancer, 69, 2124-30.
DOI
ScienceOn
|
9 |
Landoni F, Maneo A, Colombo A, et al (1997). Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet, 350, 535-40.
DOI
ScienceOn
|
10 |
Lei X, Qian CY, Qing Y, et al (2011). Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results. Int J Radiat Oncol Biol Phys, 81, 1264-70.
DOI
ScienceOn
|
11 |
Mabuchi S, Ugaki H, Isohashi F, et al (2010). Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone. Gynecol Obstet Invest, 69, 224-32.
DOI
ScienceOn
|
12 |
Montana GS, Fowler WC (1989). Carcinoma of the cervix: analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys, 16, 95-100.
DOI
ScienceOn
|
13 |
Morris M, Eifel PJ, Lu J, et al (1999). Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med, 340, 1137-43.
DOI
ScienceOn
|
14 |
Nakano T, Kato S, Ohno T, et al (2005). Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix. Cancer, 103, 92-101.
DOI
ScienceOn
|
15 |
Waggoner SE (2003). Cervical cancer. Lancet, 361, 2217-25.
DOI
ScienceOn
|
16 |
Toita T, Takizawa Y, Nakano M, et al (1994). Radical radiation therapy for adenocarcinoma of the uterine cervix. Strahlenther Onkol, 170, 277-80.
|
17 |
Uno T, Itami J, Aruga M, et al (1998). High dose rate brachytherapy for carcinoma of the cervix: risk factors for late rectal complications. Int J Radiat Oncol Biol Phys, 40, 615-21.
DOI
ScienceOn
|
18 |
Verellen D, De Ridder M, Linthout N, et al (2007). Innovations in image-guided radio therapy. Nat Rev Cancer, 7, 949-60.
DOI
ScienceOn
|
19 |
Yu ZL, Suo ZM, Yan RM, et al (2004). Retrospective analysis on 240 cervical cancer patients treated with radiotherapy. Inner Mongolia Med J, 36, 786-788.
|
20 |
Fujikawa K, Miyamoto T, Ihara Y, Matsui Y, Takeuchi H (2001). High incidence of severe urologic complications following radiotherapy for cervical cancer in Japanese women. Gynecol Oncol, 80, 21-3.
DOI
ScienceOn
|
21 |
Hanks GE, Herring DF, Kramer S (1983). Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer, 51, 959-67.
DOI
ScienceOn
|
22 |
Herrmann T, Knorr A, Dorner K (1987). [The RTOG/EORTC classification criteria for early and late radiation reactions]. Radiobiol Radiother (Berl), 28, 519-28.
|
23 |
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
DOI
|
24 |
Kapp KS, Stuecklschweiger GF, Kapp DS, et al (1997). Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol, 42, 143-53.
DOI
ScienceOn
|
25 |
Esche BA, Crook JM, Horiot JC (1987). Dosimetric methods in the optimization of radiotherapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys, 13, 1183-92.
DOI
ScienceOn
|
26 |
Niibe Y, Hayakawa K, Kanai, T, et al (2006). Optimal dose for stage IIIB adenocarcinoma of the uterine cervix on the basis of biological effective dose. Eur J Gynaecol Oncol, 27, 47-9.
|
27 |
Combes PF, Daly NJ, Horiot JC, et al (1985). Results of radiotherapy alone in 581 patients with Stage II carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys, 11, 463-71.
DOI
ScienceOn
|